期刊文献+

细胞增殖及DNA倍体不同表达与结肠癌临床分期之间的关系 被引量:1

Relationship between clinical stages and different expression of cell proliferation and DNA ploidy in colon carcinoma
暂未订购
导出
摘要 目的 研究细胞增殖核抗原 (PCNA)及 DNA倍体水平的不同表达与结肠癌临床分期和预后之间的关系。方法 应用免疫组织化学方法及图像分析技术检测 65例结肠癌患者癌组织、癌旁正常粘膜的 PCNA标记指数和 DNA相对含量。结果 结肠癌组织中 PCNA标记指数和DNA相对含量分别为 (54.7± 13 .4) %和 7.64± 3 .15,与癌周正常粘膜组织比较具有显著差异 (P<0 .0 1) ;随着 Dukes分期的进展 ,PCNA标记指数和 DNA相对含量逐渐增加 ,C、D期较 A、B期有显著差异 (P<0 .0 1)。结论 细胞增殖核抗原及 DNA倍体水平不同的表达与结肠癌的发生发展有明显的关系 ,两者可以作为结肠癌临床分期和预后的监测指标之一。 ObjectiveTo investigate the relationship between the e xpression of proliferating cell nuclear antigen(PCNA) and DNA ploidy and the cli nical stages in colon carcinoma.MethodsImmunohistochemical sta ining and computer-assisted image analysis were used to detect index of PCNA a nd nuclear DNA content in 65 cases of colon carcinoma and normal colon mucosa.ResultsIndex of PCNA and nuclear DNA content in colon carcinoma we re (54.7±13.4)% and 7.64±3.15 respectively, which were significantly differe nt as compared with those of normal colon mucosa(P<0.01). With the advanc ement of Dukes stages, the detect index of PCNA and nuclear DNA content increase d gradually, whose differences were all significant(P<0.01)in comparing C 、D stages with A、B stages.ConclusionThe different expression of PCNA and DNA ploidy are obviously related to the tumorigenesis and progres sion of colon carcinoma. Both would become one of the prognostic indicators for colon carcinoma.
出处 《新乡医学院学报》 CAS 2004年第1期17-18,22,共3页 Journal of Xinxiang Medical University
关键词 结肠癌 细胞增殖核抗原 DNA倍体 DUKES分期 colon carcinoma proliferating cell nuclear antigen DNA ploidy Dukes stages
  • 相关文献

参考文献4

二级参考文献19

共引文献24

同被引文献10

  • 1刘清云,张丰菊,罗肇文,郭建华,杨路.人工晶状体袢的角度与后发性白内障相关性研究[J].眼科新进展,2005,25(1):33-36. 被引量:3
  • 2孙润芹,王康敏,黄莺,靳耀锋.小儿皮肤血管瘤c-myc蛋白表达与其细胞增殖和凋亡的关系[J].实用儿科临床杂志,2005,20(2):147-148. 被引量:6
  • 3李娜,王洪兴,杨晓煜.VEGF和PCNA在食管鳞癌组织中的表达及其意义[J].新乡医学院学报,2005,22(6):562-564. 被引量:3
  • 4Tfelt-Hansen J,Kanuparthi D,Chattopadhyay N.The emerging role of pituitary tumor transforming gene in tumorigenesis[J].Clin Med Res,2006,4(2):130-137.
  • 5Donangelo I,Gutman S,Horvath E,et al.Pituitary tumor transforming gene overexpression facilitates pituitary tumor development[J].Endocrinology,2006,147(10):4 781-4 791.
  • 6Aratake Y,Nomura H,Kotani T,et al.Coexistent anaplastic and differentiated thyroid carcinoma:an immunohistochemical study[J].Am J Clin Pathol,2006,125(3):399-406.
  • 7Cvejic D,Savin S,Petrovic I,et al.Galectin-3 and proliferating cell nuclear antigen (PCNA) expression in papillary thyroid carcinoma[J].Exp Oncol,2005,27(3):210-214.
  • 8Kim D,Pemberton H,Stratford AL,et al.Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells[J].Oncogene,2005,24(30):4 861-4 866.
  • 9Stratford AL,Boelaert K,Tannahill LA,et al.Pituitary tumor transforming gene binding factor:a novel transforming gene in thyroid tumorigenesis[J].J Clin Endocrinol Metab,2005,90(7):4 341-4 349.
  • 10Saez C,Martinez-Brocca MA,Castilla C,et al.Prognostic significance of human pituitary tumor-transforming gene immunohistochemical expression in differentiated thyroid cancer[J].J Clin Endocrinol Metab,2006,91(4):1 404-1 409.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部